Clinical Characteristics and Outcomes of COVID-19 in West Virginia
Sijin Wen,
Apoorv Prasad,
Kerri Freeland,
Sanjiti Podury,
Jenil Patel,
Roshan Subedi,
Erum Khan,
Medha Tandon,
Saurabh Kataria,
Wesley Kimble,
Shitiz Sriwastava
Affiliations
Sijin Wen
Department of Biostatistics, West Virginia University, Morgantown, WV 26505, USA
Apoorv Prasad
Berkeley Medical Center, Department of Neurology, West Virginia University, Morgantown, WV 25401, USA
Kerri Freeland
Department of Biostatistics, West Virginia University, Morgantown, WV 26505, USA
Sanjiti Podury
Department of Medicine, Army College of Medical Sciences, New Delhi 110010, Delhi, India
Jenil Patel
Department of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Dallas, TX 75235, USA
Roshan Subedi
Research Section, Nepal Health Research Council, Kathmandu 44600, Nepal
Erum Khan
Department of Medicine, B.J. Medical College and Civil Hospital, Ahmedabad 380016, Gujarat, India
Medha Tandon
Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA 15215, USA
Saurabh Kataria
Department of Neurology, Louisiana State University, Health Sciences Center, Shreveport, LA 71130, USA
Wesley Kimble
West Virginia Clinical and Translational Science Institute, Morgantown, WV 26505, USA
Shitiz Sriwastava
West Virginia Clinical and Translational Science Institute, Morgantown, WV 26505, USA
This study examines the clinical characteristics, outcomes and types of management in SARS-CoV-2 infected patients, in the hospitals affiliated with West Virginia University. We included patients from West Virginia with SARS-CoV-2 infection between 15 April to 30 December 2020. Descriptive analysis was performed to summarize the characteristics of patients. Regression analyses were performed to assess the association between baseline characteristics and outcomes. Of 1742 patients, the mean age was 47.5 years (±22.7) and 54% of patients were female. Only 459 patients (26.3%) reported at least one baseline symptom, of which shortness of breath was most common. More than half had at least one comorbidity, with hypertension being the most common. There were 131 severe cases (7.5%), and 84 patients (4.8%) died despite treatment. The mean overall length of hospital stay was 2.6 days (±6.9). Age, male sex, and comorbidities were independent predictors of outcomes. In this study of patients with SARS-CoV-2 infection from West Virginia, older patients with underlying co-morbidities had poor outcomes, and the in-hospital mortality was similar to the national average.
